The Commodity Trap with a Premium Twist

The Most Confusing Stock in the Edible Oil Universe

Let’s establish the identity crisis first. Patanjali Foods is not a company. It’s a corporate portfolio masquerading as a company. Born as Ruchi Soya Industries (a liquidation case in 2019, acquired by Patanjali Ayurved in CIRP), it’s evolved into a bizarre multi-headed creature: part commodity processor, part direct-to-consumer FMCG beast, part plantation operator, and part nutraceutical speculator. That whirlwind transformation is why the stock has rallied 10x from ₹50 to ₹500 in five years.

But here’s the uncomfortable truth: most of that 10x came from mixing portfolio segments at different margins. Buying low-margin edible oil business, bolting on high-margin biscuits and shampoo, and watching the blended EBITDA expand is portfolio alchemy, not operational excellence. Once the mix stabilizes, where’s the next leg of growth?

Q3 FY26 is the inflection moment. The company just delivered the highest-ever quarterly revenue (₹10,484 Cr) and record 9-month results. But dive into the segment performance, and the story splits: oils are grinding along at near-single-digit growth; FMCG is booming at 39% YoY with brutal execution in distribution. The market is paying 32x P/E. Most analysts are silent because they can’t figure out how to model this beast either.

Portfolio Play Masquerading as a Conglomerate

Segment 1: Edible Oils (72% of revenue, 10% of EBITDA). Patanjali sells palm oil (Ruchi Gold), soybean oil (Mahakosh), sunflower oil (Sunrich), and unbranded commodity oil. They crush oil palm, refine it, package it, and distribute through 8,000+ distributors reaching 1.5 million retail touchpoints. Revenue: ₹7,336 Cr in Q3. EBITDA margin: 2.4%. Why so low? Commodity pricing. When palm oil prices fall 12.6% YoY globally, retailers demand lower prices. When they rise, input costs spike. The company hedges FX and commodities, but margin compression is structural. Market share: ~51% in branded automotive oils… wait, wrong company. Here, it’s palm oil at 1st position, soybean at 2nd. The margin framework is 2–4% — and management proudly targets “closer to 4%.”

Segment 2: Foods (16% of revenue, part of 11% EBITDA). Biscuits (Doodh brand), staples (atta, pulses, honey, ghee), ethnic foods. Biscuits alone crossed ₹1,000 crore in 9M FY26 sales. Growth is 26–38% YoY. Margins: ~9–10%. This is where the actual business magic happens. No commodity chaos, brand loyalty exists, and pricing power is present. Ghee in Q3 hit ₹468 Cr (seasonally strong, +46% YoY). Staples is the margin drag — ₹1,256 Cr in Q3 at lower margins because it’s a revenue driver, not a margin play. Near-term innovation: premium biscuits launching in Q4 FY26.

Segment 3: HPC — Home & Personal Care (6% of revenue, 36% of EBITDA). Dental care (₹339 Cr in Q3), hair care, skin care, home care. EBITDA margin: 25%. Dant Kanti (toothpaste) is the growth engine. Management claims dental care is the fastest-growing segment in the HPC portfolio, competing directly against Colgate and Crest. Market intensity? “Fairly intense,” management admitted. But Patanjali’s dental grew ~₹116 Cr YoY to Q3’s ₹340 Cr level, driven by variants and rural/B&C town penetration. The company targets 15% growth in HPC; it’s tracking toward that with 25% margins as proof of execution.

Segment 4: Oil Palm Plantation (1.5% of revenue, 22% EBITDA). High-margin beast. The company operates 108,000 hectares of plantation land (farmer-owned, company manages for 35 years), crushes 300,000 MT of fresh fruit bunches, and extracts 22% EBITDA margins. FY26-27 expansion: +40,000 hectares planned (20,000 Northeast, 20,000 South). This is optionality — long-term, low-leverage growth.

Q3 FY26: Record Revenue, Lumpy Profitability

Result type: Quarterly Results  |  Q3 FY26 EPS: ₹5.46  |  Annualised EPS (Q3×4): ₹21.84  |  9M FY26 EPS (cumulative): ₹11.73

Is 32x P/E Justified? Let’s Do The Math